TipRanks
dorsaVi Limited (AU:DVL)
ASX:DVL
Australian Market
Want to see AU:DVL full AI Analyst Report?

dorsaVi Limited (DVL) AI Stock Analysis

9 Followers

Top Page

AU:DVL

dorsaVi Limited

(Sydney:DVL)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - Gpt-5.6Sol)
Rating:43Neutral
Price Target:
AU$0.03
▲(30.00% Upside)
Action:Reiterated
Date:09/15/26
The score is held down primarily by weak financial performance—persistent losses, a sharp profitability deterioration in 2026, and ongoing negative operating/free cash flow. Technical indicators add a negative tilt with the stock trading below longer-term moving averages and a negative MACD. Valuation provides limited support due to negative earnings (negative P/E) and no dividend yield data.
Positive Factors
Low leverage
Very low leverage gives dorsaVi a comparatively conservative capital structure and reduces the immediate burden of interest and debt repayment. This provides greater financial flexibility to maintain operations and pursue product development, even though profitability remains weak.
Negative Factors
Persistent unprofitability
Persistent losses and the sharp 2026 deterioration indicate that the current business model has not yet achieved sustainable operating economics. Deeply negative gross profit suggests costs are overwhelming revenue at a fundamental level, limiting the ability to self-fund growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage
Very low leverage gives dorsaVi a comparatively conservative capital structure and reduces the immediate burden of interest and debt repayment. This provides greater financial flexibility to maintain operations and pursue product development, even though profitability remains weak.
Read all positive factors

dorsaVi Limited (DVL) vs. iShares MSCI Australia ETF (EWA)

dorsaVi Limited Business Overview & Revenue Model

Company Description
dorsaVi Ltd, an Australian company established in 2008 and based in Oakleigh South, focuses on creating and distributing advanced motion analysis technologies throughout Australia, Europe, and the United States. Its product portfolio includes ViMo...
How the Company Makes Money
null...

dorsaVi Limited Financial Statement Overview

Summary
Overall financial quality is weak: the company remains loss-making with sharply worsening profitability in 2026 (including deeply negative gross profit) and persistent negative operating/free cash flow indicating ongoing cash burn. The main offset is a comparatively conservative balance sheet with very low leverage, which reduces near-term solvency risk but does not resolve weak earnings power.
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
24
Negative
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue1.00M1.13M1.30M1.75M2.35M
Gross Profit-3.33M971.82K1.18M-798.43K-1.45M
EBITDA-7.36M-1.82M-1.60M-1.88M-1.53M
Net Income-8.52M-1.52M-1.25M-1.82M-1.54M
Balance Sheet
Total Assets5.85M3.97M2.18M2.69M3.36M
Cash, Cash Equivalents and Short-Term Investments2.12M2.29M478.10K878.72K449.70K
Total Debt68.25K156.89K190.17K321.85K1.18M
Total Liabilities1.51M1.14M1.16M1.01M2.13M
Stockholders Equity4.34M2.84M1.02M1.68M1.22M
Cash Flow
Free Cash Flow-5.28M-956.83K-622.08K-1.02M-2.25M
Operating Cash Flow-5.28M-956.83K-600.90K-967.41K-2.15M
Investing Cash Flow-5.64K-304.00K-21.18K-51.65K-100.34K
Financing Cash Flow5.12M3.08M227.06K1.45M-92.25K

dorsaVi Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.03
Negative
200DMA
0.03
Negative
Market Momentum
MACD
<0.01
Positive
RSI
44.91
Neutral
STOCH
-113.89
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DVL, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 44.91 is Neutral, neither overbought nor oversold. The STOCH value of -113.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DVL.

dorsaVi Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
AU$974.00M-15.15-15.51%―19.02%-140.54%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
45
Neutral
AU$15.57M-0.98136.97%―38.17%83.44%
43
Neutral
AU$30.88M-3.16-165.14%―-11.13%-280.00%
43
Neutral
AU$42.54M-4.59-23.77%―10.62%36.67%
42
Neutral
AU$60.89M-4.00-92.06%―――
41
Neutral
AU$4.48M-3.06-247.44%―17.51%43.31%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:DVL
dorsaVi Limited
0.03
-0.02
-48.98%
AU:CAT
Catapult Group International
3.18
-3.70
-53.78%
AU:X2M
X2M Connect Limited
0.01
>-0.01
-40.00%
AU:VR1
Vection Technologies Ltd.
0.02
-0.05
-75.00%
AU:AUA
Audeara Ltd.
0.02
>-0.01
-4.35%
AU:NVU
Nanoveu Ltd.
0.05
-0.04
-44.68%

dorsaVi Limited Corporate Events

dorsaVi pivots movement data and neuromorphic tech toward humanoid robotics
Sep 20, 2026
dorsaVi Limited is leveraging its long-established movement data library, wearable sensors and Video AI capabilities, which span clinical, workplace, sporting and animal applications, to move beyond its traditional sensor markets. The company also...
dorsaVi Advances Energy-Efficient RRAM for Physical AI and Robotics
Sep 13, 2026
dorsaVi Limited has begun specialised electrical measurements to characterise the energy required to update states in its engineered resistive random-access memory structures, a crucial metric for its low-power RRAM-CMOS hardware roadmap. The devi...
DorsaVi widens annual loss but boosts net assets through capital raisings and new licences
Aug 31, 2026
DorsaVi Limited reported a 5.8% increase in revenue to $1.59 million for the year ended 30 June 2026, but its loss after tax surged to $8.52 million, more than five times the prior year, with no dividends declared. Despite the deeper loss and an a...
dorsaVi Starts Fabrication of First RRAM-CMOS Validation Chip
Aug 11, 2026
dorsaVi Limited has begun silicon fabrication of its first RRAM-CMOS validation chip, with the manufacturing data package accepted into a semiconductor foundry&#8217;s production flow and wafer processing now underway. This marks a significant shi...
DorsaVi Advances Edge-AI Hardware Program for Robotics and Exoskeletons
Jul 29, 2026
DorsaVi reported a highly active June quarter as it advanced its RRAM and neuromorphic technology program for robotics and exoskeleton edge computing. The company highlighted its focus on overcoming the &#8220;memory wall&#8221; in edge devices by...
DorsaVi Launches Physical AI Sensor v6.5 for On-Device Movement Intelligence
Jul 27, 2026
DorsaVi Limited has launched Sensor v6.5, an intelligent wearable that processes human movement and delivers biofeedback directly on the device in real time, without reliance on an iPad, PC or cloud connection. Built on the company&#8217;s existin...
dorsaVi Moves 22-nm RRAM Program Into Tape-Out and Silicon Validation
Jul 14, 2026
dorsaVi Limited has begun the tape-out process for its first 22-nanometre RRAM-CMOS validation chip in collaboration with tier-one semiconductor partners, moving the project from design finalisation into physical silicon manufacturing using commer...
DorsaVi Options Lapse, Clarifying Issued Capital Structure
Jul 14, 2026
DorsaVi Ltd has notified the market of the cessation of a series of options, designated DVLAA, that expired without being exercised or converted on 5 July 2026 and 8 April 2026, respectively. The lapse of these 3,076,247 options reduces the pool o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 15, 2026